Glucose homeostasis is but a part of a more general metabolic homeostasis in which the body regulates and controls the distribution and levels of metabolites in cells. Thus nature ensures that there are always available to enzymes their appropriate substratesthe cell cannot afford to 'run out', but conversely degradation of foodstuffs is not to be encouraged unless there is a need for the energy so produced, and this is managed by control of enzymic function. Many enzymes, it has been found in recent years, are subject to complex regulation and control, the full details of which are as yet imperfectly understood and appear to get increasingly involved the more we learn (see Manchester 1967 , for a simple outline).
If we have glucose homeostasis in the extracellular compartment, we may also say that intracellularly there is a glucose-6-phosphate (G6P) homeostasis. In the liver cell the reactions using and producing G6P are numerous (Fig 1) . Although the actual concentration of G6P fluctuates more than does plasma glucose, it is none the less true to say that, given the multiplicity of reactions in which G6P participates, its concentration stays remarkably constant. This is so because many of the reactions or reaction sequences (metabolic pathways) involving it are subject to control. There are for example feedback and feedforward mechanisms -G6P activates glycogen synthetase, one of the enzymes involved in glycogen synthesis (Larner et al. 1964) . This is a positive feed-forward or forward activation because accumulation of G6P speeds up its own disposalas glycogen. Conversely, in many tissues G6P inhibits hexokinase (Walker 1966) . This is a negative feedback, for in this instance accumulation of G6P cuts back the rate of further phosphorylation of glucose.
Because of the dynamic nature of metabolism, which presumably allows more flexible control than would a static set-up, we have a continual turnover of plasma glucose. In the post-absorptive state it might be thought that plasma glucose turnover would be equivalent to total glucose oxidation (which can readily be measured as 14CO2 production from tracer [14C]glucose). glucose will in fact reform ["4C]glucose.
(2) The incorporation of plasma glucose into glycogen (through pathways as shown in Fig 1) and its reconversion to plasma glucose. An ingenious procedure for estimating the rates of the respective uses to which plasma glucose is subject has recently been put forward , Katz & Dunn 1967 , namely the use of glucose labelled with both 14C and tritium. Thus, because of the reactions by which lactate is reconverted to glucose (Fig 2) , glucose labelled in the 6 position with tritium will lose its radioactivity on going round the Cori cycle, whereas 14C remains incorporated. Glucose labelled with tritium in the 2 position will tend to lose its label in addition during glycogen synthesis and breakdown, because G6P readily equilibrates with fructose-6-phosphate. found the turnover of [2-T]glucose to be faster than [6-Tiglucose which in turn was faster than [6-4C]glucose (Fig 3) , and from this they could make estimates of the rates of some of the reactions shown in Fig 1 . In the liver (and kidney) G6P is formed by gluconeogenesiseither from lactate or from tricarboxylic acid cycle intermediates arising from degradation of amino acids. The rate and extent of gluconeogenesis is, like all metabolic pathways, subject to careful regulation (Krebs 1964 (Krebs , 1966 . Note that the sequence of reactions (Fig 2) is not precisely the same as in glycolysis, and the different enzymes involved, which are named, provide the most obvious points of control. Which is the more important is as yet uncertain and may in fact be different under different conditionsfor example, provision of NADH for the formation of triose phosphate is also of great importance (Williamson et al. 1966 , Krebs et al. 1967 ). There appears to be a strong tendency for pathways to be regulated at an early step in the sequence and on this basis the phosphoenolpyruvate carboxykinase stage would be an obvious place. It is an example of an adaptive enzyme, by which is meant that the actual concentration of the enzyme changes in different endocrine and nutritional states (Lardy 1965 .
The possibility of changed levels of an enzyme (adaptation) should be carefully distinguished from changed activity of an enzyme which may arise through product inhibition (e.g. inhibition of hexokinase by G6P) or an allosteric interaction (e.g. activation of glycogen synthetase by G6P) but which does not involve a change in the quantity of enzyme protein present. Whereas interactions of small molecules with enzymes can take place rapidly, the adaptive changes, which are important mainly for the liver, take several hours to be effective (Steiner & King 1963 , Sols et al. 1965 . Though adaptive changes are mainly under endocrine control, their role in adjustment to the changed metabolic needs in fed and fasting conditions is important. Thus there are claims for elevated levels of glycogen synthetase, glucokinase, phosphofructokinase and pyruvate kinase when glucose and insulin are readily available, whereas conversely the levels of phosphoenolpyruvate carboxykinase, fructose-1 :6-diphosphatase and glucose-6-phosphatase rise in diabetes and glucose starvation (Weber et al. 1965 , Weber et al. 1966 ). Many of the problems of how insulin and other hormones affect glucose uptake and output by the liver are probably resolvable in terms of varying activities of these enzymes (Steele 1966) .
Allosteric regulation in its simplest form involves the interaction of small molecules, not necessarily either substrates or products of the enzyme, with the enzyme protein in such a way as to change its structural conformation and hence increase or decrease its activity. Other good examples in addition to the one just referred to are activation by citrate of acetyl-CoA carboxylasethe first steps in the synthesis of fatty acids from acetyl-CoA (Numa et al. 1965 ) and activation by acetyl-CoA of pyruvate carboxylase (Utter & Keech 1963) (Fig 2) . But perhaps some of the most important instances are the complex interactions of the adenine nucleotides (AMP, ADP, ATP and cyclic AMP) with for example phosphorylase, phosphofructokinase, fructose-1 :6-diphosphatase and pyruvate kinase (Atkinson 1966 , Stadtman 1966 , Hales 1967 . Unfortunately here we run up against another problem, namely the multiplicity of forms in which the nucleotides may exist, depending on pH and the presence of Mg2+. ATP is strictly H4ATP, but at pH 8, at which many in vitro assays are carried out, exists as ATP4-. It is a curious feature that many in vitro assays are carried out at pH 8 if intracellular pH is around 7; but, to take two enzymes rather arbitrarily, neither phosphorylase kinase ) nor phosphofructokinase (Uyeda & Racker 1965 , Lowry & Passonneau 1966 , Trivedi & Danforth 1966 have been found to work very satisfactorily at pH 7 and the extent of inhibition of phosphofructokinase by ATP varied very much with the type of buffer used (Uyeda & Racker 1965) . If the pK for the fourth ionization of ATP is around pH 6-5 we have present at pH 7 0 24 % of ATP as HATP3-and 76 % as ATP4-.
In the presence of magnesium ions a chelate complex forms between the ion and the negative charges of the ATP. Thus Mg2+ +ATP4-_ --MgATP2-Since the equilibrium constant for formation of the complex is very large (about 104 or 105 moles-, Bock 1960 , Kuby & Noltmann 1962 , and since in the cell the total magnesium concentration is greater than that of ATP, it is likely that most (though not all) ATP is in the form of the magnesium complex.
In parenthesis it is interesting to note that the reaction catalysed by hexokinase is normally written in the form Mg2+ Glucose + ATP > G6P + ADP the Mg2+ above the arrow indicating that the enzyme requires magnesium ions, but equally or perhaps more correctly we can write Glucose + MgATP > G6P + MgADP indicating that it is primarily with the nucleotide that the magnesium is associated.
Mg2+ + HATP3-also produces MgHATP-but the association constant is about a hundred times less. Thus at pH 7, depending on the availability of Mg2+ we could have present four forms of ATP namely ATP4-, HATP3-, MgATP2-and MgHATP-. If the magnesium chelates are the forms normally required by enzymes using ATP, the unchelated nucleotides are very likely to be competitive inhibitors. Certainly in in vitro assays an excess of ATP over magnesium often has inhibitory effects, but this could also result if the unchelated ATP were preferentially to bind ions required by the enzyme.
But notice, also, that we have an equilibrium between all four forms which can be represented HATP3x = H+ + ATP4-
Mg2+ Mg2+
MgHATPI r H+ + MgATP2-Since the avidity of MgATP2-formation is more than 100 times that of MgHATP-, addition of Mg2+ to a mixture of HATP3-and ATP4-effectively increases its ionization; that is, we move from left to right, with consequent liberation of H+. Conversely, with limiting concentrations of Mg2+, change in pH will change not only the HATP3-/ATP4ratio but also the relative levels of the different MgATP complexes. This only applies with limiting amounts of Mg2+ because with excess cation at pH 7 everything is effectively pulled in thedirection of MgATP2 -. There is in fact more magnesium than ATP in the cell, but on the other hand ATP is not the only compound able to chelate magnesium, though it does so more strongly than most. Magnesium can also be bound by citrate and other carboxylic acids, ADP, AMP, inorganic phosphate and creatine phosphate, not to mention proteins and nucleic acids, and all these together are present in concentrations in excess of the total magnesium. Calculations (Kerson et al. 1967 ) and indirect observations (England et al. 1967 ) suggest that there is likely to be very little free Mg2+ present in the cell. Moreover, it is likely that what there is will be subject to variation by the demands of different metabolic conditions and, as pointed out, change in free Mg2+ will change amounts of chelate complexes from which a host of variations will follow. Thus, under physiological conditions, we have the possibility of a very complicated fluctuation in the concentrations of various chelate forms which are going to be subject to regulation by pH and could themselves affect the pool of H+. The more acid the intracellular pH (see, for example, papers by Butler et al. 1967, and Carter et al. 1967 , for differing estimates) the more complex the interactions. The possibilities for enzyme regulation are thus enormous.
One might have been forgiven for thinking a few years ago that metabolic pathways were well worked out. However, elucidation of the precise functioning of homeostatic control mechanisms raises a variety of new questions which should provide sufficient research to keep us all going for many years to come. 100 ml. In vitro studies of the effects of sugars other than glucose have suggested that only those sugars which are readily metabolized by mammalian tissues stimulate release. The glucose effect is suppressed by mannoheptulose (an inhibitor of hexokinase and glucokinase) but not by phloridzin (an inhibitor of glucose transporting systems). It has been suggested that the effector for insulin release may be a metabolite formed from glucose in pancreatic P-cells; and that the glucoreceptor (which determines the glucose concentration dependence) may be a hexokinase or glucokinase with a high Km for
